Chemical Structure : RMC-6236
CAS No.: 2765091-21-0
Catalog No.: PC-22125Not For Human Use, Lab Use Only.
Daraxonrasib (RMC-6236) is a first-in-class broad-spectrum RAS (ON) multi-selective inhibits, inhibits active state of both mutant and wild-type KRAS, NRAS and HRAS variants.
Packing | Price | Stock | Quantity |
---|---|---|---|
2 mg | $198 | In stock | |
5 mg | $358 | In stock | |
10 mg | $558 | In stock | |
25 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Daraxonrasib (RMC-6236) is a first-in-class broad-spectrum RAS (ON) multi-selective inhibits, inhibits active state of both mutant and wild-type KRAS, NRAS and HRAS variants.
RMC-6236 exhibits potent anticancer activity across RAS-addicted cell lines, particularly those harboring mutations at codon 12 of KRAS.
Oral administration of RMC-6236 is tolerated in vivo and drives profound tumor regressions across multiple tumor types in a mouse clinical trial with KRASG12X xenograft models.
M.Wt | 811.06 | |
Formula | C44H58N8O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(1S,2S)-N-((63S,4S,Z)-11-ethyl-12-(2-((S)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide |
1. Jiang J, et al. Cancer Discov. 2024 Apr 9:OF1-OF24.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright